[1]
|
Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., et al. (2020) Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. New England Journal, 382, 970-971. https://doi.org/10.1056/NEJMc2001468
|
[2]
|
Callaway, E., Cyranoski, D., Mallapaty, S., Stoye, E. and Tollefson, J. (2020) The Coronavirus Pandemic in Five Powerful Charts. Nature, 579, 482-483. https://doi.org/10.1038/d41586-020-00758-2
|
[3]
|
Del Pozo, V., De Andres, B., Martin, E., Maruri, N., Zubeldia, J.M., Palomino, P., et al. (1990) Murine Eosinophils and IL-1: Alpha IL-1 mRNA Detection by in Situ Hybridization. Production and Release of IL-1 from Peritoneal Eosinophils. Journal of Immunology, 144, 3117-3122.
|
[4]
|
Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., Ren, L., et al. (2020) Characterization of Spike Glycoprotein of SARS-CoV-2 on Virus Entry and Its Immune Cross-Reactivity with SARS-CoV. Nature Communications, 11, Article No. 1620. https://doi.org/10.1038/s41467-020-15562-9
|
[5]
|
van Doremalen, N., Bushmaker, T., Morris, D.H., Holbrook, M.G., Gamble, A., Williamson, B.N., et al. (2020) Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. New England Journal, 382, 1564-1567. https://doi.org/10.1056/NEJMc2004973
|
[6]
|
Wu, Z. and McGoogan, J.M. (2020) Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA, 323, 1239-1242. https://doi.org/10.1001/jama.2020.2648
|
[7]
|
Perlman, S. and Dandekar, A.A. (2005) Immunopathogenesis of Coronavirus Infections: Implications for SARS. Nature Reviews Immunology, 5, 917-927. https://doi.org/10.1038/nri1732
|
[8]
|
Senga, M., Arabi, Y.M. and Fowler, R.A. (2017) Clinical Spectrum of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Journal of Infection and Public Health, 10, 191-194. https://doi.org/10.1016/j.jiph.2016.04.008
|
[9]
|
Onder, G., Rezza, G. and Brusaferro, S. (2020) Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA, 232, 1775-1776. https://doi.org/10.1001/jama.2020.4683
|
[10]
|
Center JHCR (2020) Mortality Analyses. https://coronavirus.jhu.edu/data/mortality
|
[11]
|
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., et al. (2020) Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Internal Medicine, 180, 934-943. https://doi.org/10.1001/jamainternmed.2020.0994
|
[12]
|
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., et al. (2020) Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 323, 1061-1069. https://doi.org/10.1001/jama.2020.1585
|
[13]
|
Zeng, H., Belser, J.A., Goldsmith, C.S., Gustin, K.M., Veguilla, V., Katz, J.M., et al. (2015) A(H7N9) Virus Results in Early Induction of Proinflammatory Cytokine Responses in Both Human Lung Epithelial and Endothelial Cells and Shows Increased Human Adaptation Compared with Avian H5N1 Virus. Journal of Virology, 89, 4655-4667. https://doi.org/10.1128/JVI.03095-14
|
[14]
|
Zhou, P., Yang, X.L., Wang, X.G., Hu, B., Zhang, L., Zhang, W., et al. (2020) A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature, 579, 270-273. https://doi.org/10.1038/s41586-020-2012-7
|
[15]
|
Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y. and Zhou, Q. (2020) Structural Basis for the Recognition of SARS-CoV-2 by Full-Length Human ACE2. Science, 367, 1444-1448. https://doi.org/10.1126/science.abb2762
|
[16]
|
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Kruger, N., Herrler, T., Erichsen, S., et al. (2020) SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, 181, 271-280.e8. https://doi.org/10.1016/j.cell.2020.02.052
|
[17]
|
Belouzard, S., Chu, V.C. and Whittaker, G.R. (2009) Activation of the SARS Coronavirus Spike Protein via Sequential Proteolytic Cleavage at Two Distinct Sites. Proceedings of the National Academy of Sciences of the United States of America, 106, 5871-5876. https://doi.org/10.1073/pnas.0809524106
|
[18]
|
Millet, J.K. and Whittaker, G.R. (2015) Host Cell Proteases: Critical Determinants of Coronavirus Tropism and Pathogenesis. Virus Research, 202, 120-134. https://doi.org/10.1016/j.virusres.2014.11.021
|
[19]
|
Simmons, G., Zmora, P., Gierer, S., Heurich, A. and Pohlmann, S. (2013) Proteolytic Activation of the SARS-Coronavirus Spike Protein: Cutting Enzymes at the Cutting Edge of Antiviral Research. Antiviral Research, 100, 605-614. https://doi.org/10.1016/j.antiviral.2013.09.028
|
[20]
|
Jia, H.P., Look, D.C., Shi, L., Hickey, M., Pewe, L., Netland, J., et al. (2005) ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia. Journal of Virology, 79, 14614-14621. https://doi.org/10.1128/JVI.79.23.14614-14621.2005
|
[21]
|
Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y. and Zuo, W. (2020) Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2. American Journal of Respiratory and Critical Care Medicine, 203, 756-759. https://doi.org/10.1164/rccm.202001-0179le
|
[22]
|
Wang, Z. and Xu, X. (2020) scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells. Cells, 9, Article No. 920. https://doi.org/10.3390/cells9040920
|
[23]
|
Fehr, A.R. and Perlman, S. (2015) Coronaviruses: An Overview of Their Replication and Pathogenesis. In: Maier, H., Bickerton, E. and Britton, P., Eds., Coronaviruses, Vol. 1282, Humana Press, New York, 1-23. https://doi.org/10.1007/978-1-4939-2438-7_1
|
[24]
|
Sungnak, W., Huang, N., Becavin, C., Berg, M., Queen, R., Litvinukova, M., et al. (2020) SARS-CoV-2 Entry Factors Are Highly Expressed in Nasal Epithelial Cells Together with Innate Immune Genes. Nature Medicine, 26, 681-687. https://doi.org/10.1038/s41591-020-0868-6
|
[25]
|
Wrapp, D., Wang, N., Corbett, K.S., Goldsmith, J.A., Hsieh, C.L., Abiona, O., et al. (2020) Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation. Science, 367, 1260-1263. https://doi.org/10.1126/science.abb2507
|
[26]
|
Siu, Y.L., Teoh, K.T., Lo, J., Chan, C.M., Kien, F., Escriou, N., et al. (2008) The M, E, and N Structural Proteins of the Severe Acute Respiratory Syndrome Coronavirus Are Required for Efficient Assembly, Trafficking, and Release of Virus-Like Particles. Journal of Virology, 82, 11318-11330. https://doi.org/10.1128/JVI.01052-08
|
[27]
|
Xia, S., Zhu, Y., Liu, M., Lan, Q., Xu, W., Wu, Y., Ying, T., Liu, S., Shi, Z., Jiang, S. and Lu, L. (2020) Fusion Mechanism of 2019-nCoV and Fusion Inhibitors Targeting HR1 Domain in Spike Protein. Cellular & Molecular Immunology, 17, 765-767. https://doi.org/10.1038/s41423-020-0374-2
|
[28]
|
Frieman, M., Yount, B., Heise, M., Kopecky-Bromberg, S.A., Palese, P. and Baric, R.S. (2007) Severe Acute Respiratory Syndrome Coronavirus ORF6 Antagonizes STAT1 Function by Sequestering Nuclear Import Factors on the Rough Endoplasmic Reticulum/Golgi Membrane. Journal of Virology, 81, 9812-9824. https://doi.org/10.1128/JVI.01012-07
|
[29]
|
Siu, K.L., Chan, C.P., Kok, K.H., Chiu-Yat Woo, P. and Jin, D.Y. (2014) Suppression of Innate Antiviral Response by Severe Acute Respiratory Syndrome Coronavirus M Protein Is Mediated through the First Transmembrane Domain. Cellular & Molecular Immunology, 11, 141-149. https://doi.org/10.1038/cmi.2013.61
|
[30]
|
Akira, S., Uematsu, S. and Takeuchi, O. (2006) Pathogen Recognition and Innate Immunity. Cell, 124, 783-801. https://doi.org/10.1016/j.cell.2006.02.015
|
[31]
|
Ivashkiv, L.B. and Donlin, L.T. (2014) Regulation of Type I Interferon Responses. Nature Reviews Immunology, 14, 36-49. https://doi.org/10.1038/nri3581
|
[32]
|
Diebold, S.S., Montoya, M., Unger, H., Alexopoulou, L., Roy, P., Haswell, L.E., et al. (2003) Viral Infection Switches Non-Plasmacytoid Dendritic Cells into High Interferon Producers. Nature, 424, 324-328. https://doi.org/10.1038/nature01783
|
[33]
|
Frieman, M., Heise, M. and Baric, R. (2008) SARS Coronavirus and Innate Immunity. Virus Research, 133, 101-112. https://doi.org/10.1016/j.virusres.2007.03.015
|
[34]
|
Schneider, W.M., Chevillotte, M.D. and Rice, C.M. (2014) Interferon-Stimulated Genes: A Complex Web of Host Defenses. Annual Review of Immunology, 32, 513-545. https://doi.org/10.1146/annurev-immunol-032713-120231
|
[35]
|
Velazquez-Salinas, L., Verdugo-Rodriguez, A., Rodriguez, L.L. and Borca, M.V. (2019) The Role of Interleukin 6 during Viral Infections. Frontiers in Microbiology, 10, Article No. 1057. https://doi.org/10.3389/fmicb.2019.01057
|
[36]
|
Wu, L. and Dakic, A. (2004) Development of Dendritic Cell System. Cellular & Molecular Immunology, 1, 112-118.
|
[37]
|
Manni, M.L., Robinson, K.M. and Alcorn, J.F. (2014) A Tale of Two Cytokines: IL-17 and IL-22 in Asthma and Infection. Expert Review of Respiratory Medicine, 8, 25-42. https://doi.org/10.1586/17476348.2014.854167
|
[38]
|
Bunte, K. and Beikler, T. (2019) Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases. International Journal of Molecular Sciences, 20, Article No. 3394. https://doi.org/10.3390/ijms20143394
|
[39]
|
Channappanavar, R., Fett, C., Zhao, J., Meyerholz, D.K. and Perlman, S. (2014) Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection. Journal of Virology, 88, 11034-11044. https://doi.org/10.1128/JVI.01505-14
|
[40]
|
Pascal, K.E., Coleman, C.M., Mujica, A.O., Kamat, V., Badithe, A., Fairhurst, J., et al. (2015) Pre- and Postexposure Efficacy of Fully Human Antibodies against Spike Protein in a Novel Humanized Mouse Model of MERS-CoV Infection. Proceedings of the National Academy of Sciences of the United States of America, 112, 8738-8743. https://doi.org/10.1073/pnas.1510830112
|
[41]
|
Yao, X.H., Li, T.Y., He, Z.C., Ping, Y.F., Liu, H.W., Yu, S.C., et al. (2020) A Pathological Report of Three COVID-19 Cases by Minimally Invasive Autopsies. Zhonghua Bing Li Xue Za Zhi, 49, E009.
|
[42]
|
Rabi, F.A., Al Zoubi, M.S., Kasasbeh, G.A., Salameh, D.M. and Al-Nasser, A.D. (2020) SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far. Pathogens, 9, Article No. 231. https://doi.org/10.3390/pathogens9030231
|
[43]
|
Wolfel, R., Corman, V.M., Guggemos, W., Seilmaier, M., Zange, S., Muller, M.A., et al. (2020) Author Correction: Virological Assessment of Hospitalized Patients with COVID-2019. Nature, 588, E35. https://doi.org/10.1038/s41586-020-2984-3
|
[44]
|
Coleman, C.M., Liu, Y.V., Mu, H., Taylor, J.K., Massare, M., Flyer, D.C., et al. (2014) Purified Coronavirus Spike Protein Nanoparticles Induce Coronavirus Neutralizing Antibodies in Mice. Vaccine, 32, 3169-3174. https://doi.org/10.1016/j.vaccine.2014.04.016
|
[45]
|
Chen, W., Xu, Z., Mu, J., Yang, L., Gan, H., Mu, F., et al. (2004) Antibody Response and Viraemia during the Course of Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus Infection. Journal of Medical Microbiology, 53, 435-438. https://doi.org/10.1099/jmm.0.45561-0
|
[46]
|
Gralinski, L.E., Sheahan, T.P., Morrison, T.E., Menachery, V.D., Jensen, K., Leist, S.R., et al. (2018) Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. mBio, 9, e01753-18. https://doi.org/10.1128/mBio.01753-18
|
[47]
|
Astuti, I. and Ysrafil (2020) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An Overview of Viral Structure and Host Response. Diabetes & Metabolic Syndrome, 14, 407-412. https://doi.org/10.1016/j.dsx.2020.04.020
|
[48]
|
Channappanavar, R., Fehr, A.R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D.K., et al. (2016) Dysregulated Type I Interferon and Inflammatory Mono-cyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe, 19, 181-193. https://doi.org/10.1016/j.chom.2016.01.007
|
[49]
|
Shaw, A.C., Goldstein, D.R. and Montgomery, R.R. (2013) Age-Dependent Dysregulation of Innate Immunity. Nature Reviews Immunology, 13, 875-887. https://doi.org/10.1038/nri3547
|
[50]
|
Teijaro, J.R., Walsh, K.B., Rice, S., Rosen, H. and Oldstone, M.B. (2014) Mapping the Innate Signaling Cascade Essential for Cytokine Storm during Influenza Virus infection. Proceedings of the National Academy of Sciences of the United States of America, 111, 3799-804. https://doi.org/10.1073/pnas.1400593111
|
[51]
|
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., et al. (2020) Clinical and Immunological Features of Severe and Moderate Coronavirus Disease 2019. Journal of Clinical Investigation, 130, 2620-2629.
|
[52]
|
Ling, Y., Xu, S.B., Lin, Y.X., Tian, D., Zhu, Z.Q., Dai, F.H., et al. (2020) Persistence and Clearance of Viral RNA in 2019 Novel Coronavirus Disease Rehabilitation Patients. Chinese Medical Journal, 133, 1039-1043. https://doi.org/10.1097/CM9.0000000000000774
|
[53]
|
de Groot-Mijnes, J.D., van Dun, J.M., van der Most, R.G. and de Groot, R.J. (2005) Natural History of a Recurrent Feline Coronavirus Infection and the Role of Cellular Immunity in Survival and Disease. Journal of Virology, 79, 1036-1044. https://doi.org/10.1128/JVI.79.2.1036-1044.2005
|
[54]
|
Cheung, C.Y., Poon, L.L., Ng, I.H., Luk, W., Sia, S.F., Wu, M.H., et al. (2005) Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages in Vitro: Possible Relevance to Pathogenesis. Journal of Virology, 79, 7819-7826. https://doi.org/10.1128/JVI.79.12.7819-7826.2005
|
[55]
|
Law, H.K., Cheung, C.Y., Ng, H.Y., Sia, S.F., Chan, Y.O., Luk, W., et al. (2005) Chemokine Up-Regulation in SARS-Coronavirus-Infected, Monocyte-Derived Human Dendritic Cells. Blood, 106, 2366-2374. https://doi.org/10.1182/blood-2004-10-4166
|
[56]
|
Yen, Y.T., Liao, F., Hsiao, C.H., Kao, C.L., Chen, Y.C. and Wu-Hsieh, B.A. (2006) Modeling the Early Events of Severe Acute Respiratory Syndrome Coronavirus Infection in Vitro. Journal of Virology, 80, 2684-2693. https://doi.org/10.1128/JVI.80.6.2684-2693.2006
|
[57]
|
Chu, C.M., Poon, L.L., Cheng, V.C., Chan, K.S., Hung, I.F., Wong, M.M., et al. (2004) Initial Viral Load and the Outcomes of SARS. Canadian Medical Association Journal, 171, 1349-1352. https://doi.org/10.1503/cmaj.1040398
|
[58]
|
Peiris, J.S., Chu, C.M., Cheng, V.C., Chan, K.S., Hung, I.F., Poon, L.L., et al. (2003) Clinical Progression and Viral Load in a Community Outbreak of Coronavirus-Associated SARS Pneumonia: A Prospective Study. Lancet, 361, 1767-1772. https://doi.org/10.1016/S0140-6736(03)13412-5
|
[59]
|
Roberts, A., Deming, D., Paddock, C.D., Cheng, A., Yount, B., Vogel, L., et al. (2007) A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice. PLoS Pathogens, 3, e5. https://doi.org/10.1371/journal.ppat.0030005
|
[60]
|
Zhang, T., Sun, L.X. and Feng, R.E. (2020) Comparison of Clinical and Pathological Features between Severe Acute Respiratory Syndrome and Coronavirus Disease 2019. Chinese Journal of Tuberculosis and Respiratory Diseases, 43, E040.
|
[61]
|
Herold, S., Steinmueller, M., von Wulffen, W., Cakarova, L., Pinto, R., Pleschka, S., et al. (2008) Lung Epithelial Apoptosis in Influenza Virus Pneumonia: The Role of Macrophage-Expressed TNF-Related Apoptosis-Inducing Ligand. Journal of Experimental Medicine, 205, 3065-3077. https://doi.org/10.1084/jem.20080201
|
[62]
|
Rodrigue-Gervais, I.G., Labbe, K., Dagenais, M., Dupaul-Chicoine, J., Champagne, C., Morizot, A., et al. (2014) Cellular Inhibitor of Apoptosis Protein cIAP2 Protects against Pulmonary Tissue Necrosis during Influenza Virus Infection to Promote Host Survival. Cell Host & Microbe, 15, 23-35. https://doi.org/10.1016/j.chom.2013.12.003
|
[63]
|
Zhao, J., Zhao, J. and Perlman, S. (2010) T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice. Journal of Virology, 84, 9318-9325. https://doi.org/10.1128/JVI.01049-10
|
[64]
|
Fisman, D.N. (2000) Hemophagocytic Syndromes and Infection. Emerging Infectious Diseases, 6, 601-608.
|
[65]
|
Mehta, P., McAuley, D.F., Brown, M., Sanchez, E., Tattersall, R.S., Manson, J.J., et al. (2020) COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression. Lancet, 395, 1033-1034. https://doi.org/10.1016/S0140-6736(20)30628-0
|
[66]
|
Ruan, Q., Yang, K., Wang, W., Jiang, L. and Song, J. (2020) Clinical Predictors of Mortality Due to COVID-19 Based on an Analysis of Data of 150 Patients from Wuhan, China. Intensive Care Medicine, 46, 846-848. https://doi.org/10.1007/s00134-020-05991-x
|
[67]
|
Chen, J., Lau, Y.F., Lamirande, E.W., Paddock, C.D., Bartlett, J.H., Zaki, S.R., et al. (2010) Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+ T Cells Are Important in Control of SARS-CoV Infection. Journal of Virology, 84, 1289-1301. https://doi.org/10.1128/JVI.01281-09
|
[68]
|
Li, X., Geng, M., Peng, Y., Meng, L. and Lu, S. (2020) Molecular Immune Pathogenesis and Diagnosis of COVID-19. Journal of Pharmaceutical Analysis, 10, 102-108. https://doi.org/10.1016/j.jpha.2020.03.001
|
[69]
|
Tisoncik, J.R., Korth, M.J., Simmons, C.P., Farrar, J., Martin, T.R. and Katze, M.G. (2012) Into the Eye of the Cytokine Storm. Microbiology and Molecular Biology Reviews, 76, 16-32. https://doi.org/10.1128/MMBR.05015-11
|
[70]
|
Yang, Y., Shen, C., Li, J., Yuan, J., Yang, M., Wang, F., et al. (2020) Exuberant Elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 Infection Is Associated with Disease Severity and Fatal Outcome. medRxiv. https://doi.org/10.1101/2020.03.02.20029975
|
[71]
|
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet, 395, 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
|
[72]
|
Henry, B.M., de Oliveira, M.H.S., Benoit, S., Plebani, M. and Lippi, G. (2020) Hematologic, Biochemical and Immune Biomarker Abnormalities Associated with Severe Illness and Mortality in Coronavirus Disease 2019 (COVID-19): A Meta-Analysis. Clinical Chemistry and Laboratory Medicine, 58, 1021-1028. https://doi.org/10.1515/cclm-2020-0369
|
[73]
|
Assiri, A., Al-Tawfiq, J.A., Al-Rabeeah, A.A., Al-Rabiah, F.A., Al-Hajjar, S,. Al-Barrak, A., et al. (2013) Epidemiological, Demographic, and Clinical Characteristics of 47 Cases of Middle East Respiratory Syndrome Coronavirus Disease from Saudi Arabia: A Descriptive Study. The Lancet Infectious Diseases, 13, 752-761. https://doi.org/10.1016/S1473-3099(13)70204-4
|
[74]
|
Weiskopf, D., Weinberger, B. and Grubeck-Loebenstein, B. (2009) The Aging of the Immune System. Transplant International, 22, 1041-1050. https://doi.org/10.1111/j.1432-2277.2009.00927.x
|
[75]
|
Baas, T., Roberts, A., Teal, T.H., Vogel, L., Chen, J., Tumpey, T.M., et al. (2008) Genomic Analysis Reveals Age-Dependent Innate Immune Responses to Severe Acute Respiratory Syndrome Coronavirus. Journal of Virology, 82, 9465-9476. https://doi.org/10.1128/JVI.00489-08
|
[76]
|
Channappanavar, R. and Perlman, S. (2017) Pathogenic Human Coronavirus Infections: Causes and Consequences of Cytokine Storm and Immunopathology. Seminars in Immunopathology, 39, 529-539. https://doi.org/10.1007/s00281-017-0629-x
|
[77]
|
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., et al. (2020) Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. Lancet, 395, 507-513. https://doi.org/10.1016/S0140-6736(20)30211-7
|
[78]
|
Fu, L., Wang, B., Yuan, T., Chen, X., Ao, Y., Fitzpatrick, T., et al. (2020) Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in China: A Systematic Review and Meta-Analysis. Journal of Infection, 80, 656-665. https://doi.org/10.1016/j.jinf.2020.03.041
|
[79]
|
Lauer, S.A., Grantz, K.H., Bi, Q., Jones, F.K., Zheng, Q., Meredith, H.R., et al. (2020) The Incubation Period of Coronavirus Disease 2019 (COVID-19) from Publicly Reported Confirmed Cases: Estimation and Application. Annals of Internal Medicine, 172, 577-582. https://doi.org/10.7326/M20-0504
|
[80]
|
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., et al. (2020) Kidney Disease Is Associated with In-Hospital Death of Patients with COVID-19. Kidney International, 97, 829-838. https://doi.org/10.1016/j.kint.2020.03.005
|
[81]
|
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., et al. (2020) Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiology, 5, 811-818. https://doi.org/10.1001/jamacardio.2020.1017
|
[82]
|
Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., et al. (2020) Association of Cardiac Injury with Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiology, 5, 802-810. https://doi.org/10.1001/jamacardio.2020.0950
|
[83]
|
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., et al. (2020) Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet, 395, 1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
|
[84]
|
Nicholls, J.M., Poon, L.L., Lee, K.C., Ng, W.F., Lai, S.T., Leung, C.Y., et al. (2003) Lung Pathology of Fatal Severe Acute Respiratory Syndrome. Lancet, 361, 1773-1778. https://doi.org/10.1016/S0140-6736(03)13413-7
|
[85]
|
Peiris, J.S., Guan, Y. and Yuen, K.Y. (2004) Severe Acute Respiratory Syndrome. Nature Medicine, 10, S88-S97. https://doi.org/10.1038/nm1143
|
[86]
|
Gu, J., Gong, E., Zhang, B., Zheng, J., Gao, Z., Zhong, Y., et al. (2005) Multiple Organ Infection and the Pathogenesis of SARS. Journal of Experimental Medicine, 202, 415-424. https://doi.org/10.1084/jem.20050828
|
[87]
|
Hwang, D.M., Chamberlain, D.W., Poutanen, S.M., Low, D.E., Asa, S.L. and Butany, J. (2005) Pulmonary Pathology of Severe Acute Respiratory Syndrome in Toronto. Modern Pathology, 18, 1-10. https://doi.org/10.1038/modpathol.3800247
|
[88]
|
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., et al. (2020) Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China. Clinical Infectious Diseases, 71, 762-768. https://doi.org/10.1093/cid/ciaa248
|
[89]
|
Belkaid, Y. and Rouse, B.T. (2005) Natural Regulatory T Cells in Infectious Disease. Nature Immunology, 6, 353-360. https://doi.org/10.1038/ni1181
|
[90]
|
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., et al. (2005) Angiotensin-Converting Enzyme 2 Protects from Severe Acute Lung Failure. Nature, 436, 112-116. https://doi.org/10.1038/nature03712
|
[91]
|
Lambert, D.W., Yarski, M., Warner, F.J., Thornhill, P., Parkin, E.T., Smith, A.I., et al. (2005) Tumor Necrosis Factor-Alpha Convertase (ADAM17) Mediates Regulated Ectodomain Shedding of the Severe-Acute Respiratory Syndrome-Coronavirus (SARS-CoV) Receptor, Angiotensin-Converting Enzyme-2 (ACE2). Journal of Biological Chemistry, 280, 30113-301199. https://doi.org/10.1074/jbc.M505111200
|
[92]
|
Zou, Z., Yan, Y., Shu, Y., Gao, R., Sun, Y., Li, X., et al. (2014) Angiotensin-Converting Enzyme 2 Protects from Lethal Avian Influenza A H5N1 Infections. Nature Communications, 5, Article No. 3594. https://doi.org/10.1038/ncomms4594
|
[93]
|
Monteil, V., Kwon, H., Prado, P., Hagelkruys, A., Wimmer, R.A., Stahl, M., et al. (2020) Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. Cell, 181, 905-913.e7. https://doi.org/10.1016/j.cell.2020.04.004
|
[94]
|
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F., Chong, M., et al. (2020) Characteristics and Outcomes of 21 Critically Ill Patients with COVID-19 in Washington State. JAMA, 323, 1612-1614. https://doi.org/10.1001/jama.2020.4326
|
[95]
|
Inciardi, R.M., Lupi, L., Zaccone, G., Italia, L., Raffo, M., Tomasoni, D., et al. (2020) Cardiac Involvement in a Patient with Coronavirus Disease 2019 (COVID-19). JAMA Cardiology, 5, 189-824. https://doi.org/10.1001/jamacardio.2020.1096
|
[96]
|
Lippi, G., Lavie, C.J. and Sanchis-Gomar, F. (2020) Cardiac Troponin I in Patients with Coronavirus Disease 2019 (COVID-19): Evidence from a Meta-Analysis. Progress in Cardiovascular Diseases, 63, 390-391. https://doi.org/10.1016/j.pcad.2020.03.001
|
[97]
|
Crackower, M.A., Sarao, R., Oudit, G.Y., Yagil, C., Kozieradzki, I., Scanga, S.E., et al. (2002) Angiotensin-Converting Enzyme 2 Is an Essential Regulator of Heart Function. Nature, 417, 822-828. https://doi.org/10.1038/nature00786
|
[98]
|
Oudit, G.Y., Kassiri, Z., Jiang, C., Liu, P.P., Poutanen, S.M., Penninger, J.M., et al. (2009) SARS-Coronavirus Modulation of Myocardial ACE2 Expression and Inflammation in Patients with SARS. European Journal of Clinical Investigation, 39, 618-625. https://doi.org/10.1111/j.1365-2362.2009.02153.x
|
[99]
|
Ding, Y., Wang, H., Shen, H., Li, Z., Geng, J., Han, H., et al. (2003) The Clinical Pathology of Severe Acute Respiratory Syndrome (SARS): A Report from China. The Journal of Pathology, 200, 282-289. https://doi.org/10.1002/path.1440
|
[100]
|
Natanson, C., Eichenholz, P.W., Danner, R.L., Eichacker, P.Q., Hoffman, W.D., Kuo, G.C., et al. (1989) Endotoxin and Tumor Necrosis Factor Challenges in Dogs Simulate the Cardiovascular Profile of Human Septic Shock. Journal of Experimental Medicine, 169, 823-832. https://doi.org/10.1084/jem.169.3.823
|
[101]
|
Pathan, N., Hemingway, C.A., Alizadeh, A.A., Stephens, A.C., Boldrick, J.C., Oragui, E.E., et al. (2004) Role of Interleukin 6 in Myocardial Dysfunction of Meningococcal Septic Shock. Lancet, 363, 203-209. https://doi.org/10.1016/S0140-6736(03)15326-3
|
[102]
|
Stanzani, G., Duchen, M.R. and Singer, M. (2019) The Role of Mitochondria in Sepsis-Induced Cardiomyopathy. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1865, 759-773. https://doi.org/10.1016/j.bbadis.2018.10.011
|
[103]
|
Epelman, S., Tang, W.H., Chen, S.Y., Van Lente, F., Francis, G.S. and Sen, S. (2008) Detection of Soluble, Angiotensin-Converting Enzyme 2 in Heart Failure: Insights into the Endogenous Counter-Regulatory Pathway of the Renin-Angiotensin-Aldosterone System. Journal of the American College of Cardiology, 52, 750-744. https://doi.org/10.1016/j.jacc.2008.02.088
|
[104]
|
Rutschow, S., Li, J., Schultheiss, H.P. and Pauschinger, M. (2006) Myocardial Proteases and Matrix Remodeling in Inflammatory Heart Disease. Cardiovascular Research, 69, 646-656. https://doi.org/10.1016/j.cardiores.2005.12.009
|
[105]
|
Chen, L., Li, X., Chen, M., Feng, Y. and Xiong, C. (2020) The ACE2 Expression in Human Heart Indicates New Potential Mechanism of Heart Injury among Patients Infected with SARS-CoV-2. Cardiovascular Research, 116, 1097-1100. https://doi.org/10.1093/cvr/cvaa078
|
[106]
|
Thomas, M.C., Pickering, R.J., Tsorotes, D., Koitka, A., Sheehy, K., Bernardi, S., et al. (2010) Genetic Ace2 Deficiency Accentuates Vascular Inflammation and Atherosclerosis in the ApoE Knock-out Mouse. Circulation Research, 107, 888-897. https://doi.org/10.1161/CIRCRESAHA.110.219279
|
[107]
|
Wang, K., Gheblawi, M. and Oudit, G.Y. (2020) Angiotensin Converting Enzyme 2: A Double-Edged Sword. Circulation, 142, 426-428. https://doi.org/10.1161/CIRCULATIONAHA.120.047049
|
[108]
|
Corrales-Medina, V.F., Alvarez, K.N., Weissfeld, L.A., Angus, D.C., Chirinos, J.A., Chang, C.C., et al. (2015) Association between Hospitalization for Pneumonia and Subsequent Risk of Cardiovascular Disease. JAMA, 313, 264-274. https://doi.org/10.1001/jama.2014.18229
|
[109]
|
Violi, F., Cangemi, R. and Calvieri, C. (2014) Pneumonia, Thrombosis and Vascular Disease. Journal of Thrombosis and Haemostasis, 12, 1391-1400. https://doi.org/10.1111/jth.12646
|
[110]
|
Mogensen, T.H. (2009) Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses. Clinical Microbiology Reviews, 22, 240-273. https://doi.org/10.1128/CMR.00046-08
|
[111]
|
Vallance, P., Collier, J. and Bhagat, K. (1997) Infection, Inflammation, and Infarction: Does Acute Endothelial Dysfunction Provide a Link? Lancet, 349, 1391-1392. https://doi.org/10.1016/S0140-6736(96)09424-X
|
[112]
|
Libby, P. and Simon, D.I. (2001) Inflammation and Thrombosis: The Clot Thickens. Circulation, 103, 1718-1720. https://doi.org/10.1161/01.CIR.103.13.1718
|
[113]
|
Li, Z., Wu, M., Yao, J., Guo, J., Liao X, Song S, et al. (2020) Caution on Kidney Dysfunctions of COVID-19 Patients. medRxiv. https://doi.org/10.1101/2020.02.08.20021212
|
[114]
|
Chu, K.H., Tsang, W.K., Tang, C.S., Lam, M.F., Lai, F.M., To, K.F., et al. (2005) Acute Renal Impairment in Coronavirus-Associated Severe Acute Respiratory Syndrome. Kidney International, 67, 698-705. https://doi.org/10.1111/j.1523-1755.2005.67130.x
|
[115]
|
Batlle, D., Soler, M.J., Sparks, M.A., Hiremath, S., South, A.M., Welling, P.A., et al. (2020) Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology. Journal of the American Society of Nephrology, 31, 1380-1383. https://doi.org/10.1681/ASN.2020040419
|
[116]
|
Su, H., Yang, M., Wan, C., Yi, L.X., Tang, F., Zhu, H.Y., et al. (2020) Renal Histopathological Analysis of 26 Postmortem Findings of Patients with COVID-19 in China. Kidney International, 98, 219-227. https://doi.org/10.1016/j.kint.2020.04.003
|
[117]
|
Hamming, I., Timens, W., Bulthuis, M.L., Lely, A.T., Navis, G. and van Goor, H. (2004) Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis. The Journal of Pathology, 203, 631-637. https://doi.org/10.1002/path.1570
|
[118]
|
Li, J., Li, R.J., Lv, G.Y. and Liu, H.Q. (2015) The Mechanisms and Strategies to Protect from Hepatic Ischemia-Reperfusion Injury. European Review for Medical and Pharmacological Sciences, 19, 2036-2047.
|
[119]
|
Li, L., Li, S., Xu, M., Yu, P., Zheng, S., Duan, Z., et al. (2020) Risk Factors Related to Hepatic Injury in Patients with Corona Virus Disease 2019. medRxiv. https://doi.org/10.1101/2020.02.28.20028514
|
[120]
|
Tian, S., Xiong, Y., Liu, H., Niu, L., Guo, J., Liao, M., et al. (2020) Pathological Study of the 2019 Novel Coronavirus Disease (COVID-19) through Postmortem Core Biopsies. Modern Pathology, 33, 1007-1014. https://doi.org/10.1038/s41379-020-0536-x
|
[121]
|
Levi, M., van der Poll, T., ten Cate, H. and van Deventer, S.J. (1997) The Cytokine-Mediated Imbalance between Coagulant and Anticoagulant Mechanisms in Sepsis and Endotoxaemia. European Journal of Clinical Investigation, 27, 3-9. https://doi.org/10.1046/j.1365-2362.1997.570614.x
|
[122]
|
Page, M.J., Bester, J. and Pretorius, E. (2018) The Inflammatory Effects of TNF-α and Complement Component 3 on Coagulation. Scientific Reports, 8, Article No, 1812. https://doi.org/10.1038/s41598-018-20220-8
|
[123]
|
Herbert, J.M., Savi, P., Laplace, M.C. and Lale, A. (1992) IL-4 Inhibits LPS-, IL-1β- and TNFα-Induced Expression of Tissue Factor in Endothelial Cells and Monocytes. FEBS Letters, 310, 31-33. https://doi.org/10.1016/0014-5793(92)81139-D
|
[124]
|
van der Poll, T., Buller, H.R., ten Cate, H., Wortel, C.H., Bauer, K.A., van Deventer, S.J., et al. (1990) Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal Subjects. New England Journal of Medicine, 322, 1622-1167. https://doi.org/10.1056/NEJM199006073222302
|
[125]
|
Cox, D., Kerrigan, S.W. and Watson, S.P. (2011) Platelets and the Innate Immune System: Mechanisms of Bacterial-Induced Platelet Activation. Journal of Thrombosis and Haemostasis, 9, 1097-1107. https://doi.org/10.1111/j.1538-7836.2011.04264.x
|
[126]
|
Nencioni, A., Trzeciak, S. and Shapiro, N.I. (2009) The Microcirculation as a Diagnostic and Therapeutic Target in Sepsis. Internal and Emergency Medicine, 4, 413- 418. https://doi.org/10.1007/s11739-009-0297-5
|
[127]
|
Boisrame-Helms, J., Kremer, H., Schini-Kerth, V. and Meziani, F. (2013) Endothelial Dysfunction in Sepsis. Current Vascular Pharmacology, 11, 150-160. https://doi.org/10.2174/157016113805290317
|
[128]
|
Tsai, L.K., Hsieh, S.T. and Chang, Y.C. (2005) Neurological Manifestations in Severe Acute Respiratory Syndrome. Acta Neurologica Taiwanica, 14, 113-119.
|
[129]
|
Mizuguchi, M., Yamanouchi, H., Ichiyama, T. and Shiomi, M. (2007) Acute Encephalopathy Associated with Influenza and Other Viral Infections. Acta Neurologica Scandinavica. Supplementum, 115, 45-56. https://doi.org/10.1111/j.1600-0404.2007.00809.x
|
[130]
|
Kim, J.E., Heo, J.H., Kim, H.O., Song, S.H., Park, S.S., Park, T.H., et al. (2017) Neurological Complications during Treatment of Middle East Respiratory Syndrome. Journal of Clinical Neurology, 13, 227-233. https://doi.org/10.3988/jcn.2017.13.3.227
|
[131]
|
Arbour, N., Day, R., Newcombe, J. and Talbot, P.J. (2000) Neuroinvasion by Human Respiratory Coronaviruses. Journal of Virology, 74, 8913-8921. https://doi.org/10.1128/JVI.74.19.8913-8921.2000
|
[132]
|
Murray, R.S., Brown, B., Brian, D. and Cabirac, G.F. (1992) Detection of Coronavirus RNA and Antigen in Multiple Sclerosis Brain. Annals of Neurology, 31, 525-533. https://doi.org/10.1002/ana.410310511
|
[133]
|
Cristallo, A., Gambaro, F., Biamonti, G., Ferrante, P., Battaglia, M. and Cereda, P.M. (1997) Human Coronavirus Polyadenylated RNA Sequences in Cerebrospinal Fluid from Multiple Sclerosis Patients. New Microbiologica, 20, 105-114.
|
[134]
|
Gutierrez-Ortiz, C., Mendez-Guerrero, A., Rodrigo-Rey, S., San Pedro-Murillo, E., Bermejo-Guerrero, L., Gordo-Manas, R., et al. (2020) Miller Fisher Syndrome and Polyneuritis Cranialis in COVID-19. Neurology, 95, e601-e605. https://doi.org/10.1212/WNL.0000000000009619
|
[135]
|
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., et al. (2020) Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurology, 77, 683-690. https://doi.org/10.1001/jamaneurol.2020.1127
|
[136]
|
Giacomelli, A., Pezzati, L., Conti, F., Bernacchia, D., Siano, M., Oreni, L., et al. (2020) Self-Reported Olfactory and Taste Disorders in Patients with Severe Acute Respiratory Coronavirus 2 Infection: A Cross-Sectional Study. Clinical Infectious Diseases, 71, 889-980. https://doi.org/10.1093/cid/ciaa330
|
[137]
|
Guo, Y.R., Cao, Q.D., Hong, Z.S., Tan, Y.Y., Chen, S.D., Jin, H.J., et al. (2020) The Origin, Transmission and Clinical Therapies on Coronavirus Disease 2019 (COVID-19) Outbreak—An Update on the Status. Military Medical Research, 7, Article No. 11. https://doi.org/10.1186/s40779-020-00240-0
|
[138]
|
Baig, A.M. and Sanders, E.C. (2020) Potential Neuroinvasive Pathways of SARS-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease-2019 (COVID-19). Journal of Medical Virology, 92, 1845-1857. https://doi.org/10.1002/jmv.26105
|
[139]
|
Li, Y., Fu, L., Gonzales, D.M. and Lavi, E. (2004) Coronavirus Neurovirulence Correlates with the Ability of the Virus to Induce Proinflammatory Cytokine Signals from Astrocytes and Microglia. Journal of Virology, 78, 3398-3406. https://doi.org/10.1128/JVI.78.7.3398-3406.2004
|
[140]
|
Chen, C., Zhang, X.R., Ju, Z.Y. and He, W.F. (2020) Advances in the Research of Mechanism and Related Immunotherapy on the Cytokine Storm Induced by Coronavirus Disease 2019. Chinese Journal of Burns, 36, 471-475.
|
[141]
|
Sankowski, R., Mader, S. and Valdes-Ferrer, S.I. (2015) Systemic Inflammation and the Brain: Novel Roles of Genetic, Molecular, and Environmental Cues as Drivers of Neurodegeneration. Frontiers in Cellular Neuroscience, 9, Article No. 28. https://doi.org/10.3389/fncel.2015.00028
|
[142]
|
Desforges, M., Le Coupanec, A., Dubeau, P., Bourgouin, A., Lajoie, L., Dube, M., et al. (2019) Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses, 12, Article No. 14. https://doi.org/10.3390/v12010014
|
[143]
|
Baig, A.M., Khaleeq, A., Ali, U. and Syeda, H. (2020) Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chemical Neuroscience, 11, 995-998. https://doi.org/10.1021/acschemneuro.0c00122
|
[144]
|
McAbee, G.N., Brosgol, Y., Pavlakis, S., Agha, R. and Gaffoor, M. (2020) Encephalitis Associated with COVID-19 Infection in an 11-Year-Old Child. Pediatric Neurology, 109, 94. https://doi.org/10.1016/j.pediatrneurol.2020.04.013
|
[145]
|
Li, Y.C., Bai, W.Z. and Hashikawa, T. (2020) The Neuroinvasive Potential of SARS-CoV2 May Play a Role in the Respiratory Failure of COVID-19 Patients. Journal of Medical Virology, 92, 552-555. https://doi.org/10.1002/jmv.25728
|
[146]
|
Butowt, R. and Bilinska, K. (2020) SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection. ACS Chemical Neuroscience, 11, 1200-1203. https://doi.org/10.1021/acschemneuro.0c00172
|
[147]
|
Perlman, S., Evans, G. and Afifi, A. (1990) Effect of Olfactory Bulb Ablation on Spread of a Neurotropic Coronavirus into the Mouse Brain. Journal of Experimental Medicine, 172, 1127-1132. https://doi.org/10.1084/jem.172.4.1127
|
[148]
|
Netland, J., Meyerholz, D.K., Moore, S., Cassell, M. and Perlman, S. (2008) Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2. Journal of Virology, 82, 7264-7275. https://doi.org/10.1128/JVI.00737-08
|
[149]
|
Li, Y.C., Bai, W.Z., Hirano, N., Hayashida, T., Taniguchi, T., Sugita, Y., et al. (2013) Neurotropic Virus Tracing Suggests a Membranous-Coating-Mediated Mechanism for Transsynaptic Communication. Journal of Comparative Neurology, 521, 203-312. https://doi.org/10.1002/cne.23171
|
[150]
|
Moriguchi, T., Harii, N., Goto, J., Harada, D., Sugawara, H., Takamino, J., et al. (2020) A First Case of Meningitis/Encephalitis Associated with SARS-Coronavirus-2. International Journal of Infectious Diseases, 94, 55-58. https://doi.org/10.1016/j.ijid.2020.03.062
|
[151]
|
Domingues, R.B., Mendes-Correa, M.C., de Moura Leite, F.B.V., Sabino, E.C., Salarini, D.Z., Claro, I., et al. (2020) First Case of SARS-COV-2 Sequencing in Cerebrospinal Fluid of a Patient with Suspected Demyelinating Disease. Journal of Neurology, 267, 3154-3156. https://doi.org/10.1007/s00415-020-09996-w
|
[152]
|
Bonetti, P.O., Lerman, L.O. and Lerman, A. (2003) Endothelial Dysfunction: A Marker of Atherosclerotic Risk. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 168-175. https://doi.org/10.1161/01.ATV.0000051384.43104.FC
|
[153]
|
Paniz-Mondolfi, A., Bryce, C., Grimes, Z., Gordon, R.E., Reidy, J., Lednicky, J., et al. (2020) Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Journal of Medical Virology, 92, 699-702. https://doi.org/10.1002/jmv.25915
|
[154]
|
McCray Jr., P.B., Pewe, L., Wohlford-Lenane, C., Hickey, M., Manzel, L., Shi, L., et al. (2007) Lethal Infection of K18-hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus. Journal of Virology, 81, 813-821. https://doi.org/10.1128/JVI.02012-06
|
[155]
|
Xia, H. and Lazartigues, E. (2010) Angiotensin-Converting Enzyme 2: Central Regulator for Cardiovascular Function. Current Hypertension Reports, 12, 170-175. https://doi.org/10.1007/s11906-010-0105-7
|
[156]
|
Glowacka, I., Bertram, S., Herzog, P., Pfefferle, S., Steffen, I., Muench, M.O., et al. (2010) Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63. Journal of Virology, 84, 1198-1205. https://doi.org/10.1128/JVI.01248-09
|
[157]
|
Abdennour, L., Zeghal, C., Deme, M. and Puybasset, L. (2012) Interaction Brain-Lungs. Annales Françaises d’Anesthésie et de Réanimation, 31, e101-e107. https://doi.org/10.1016/j.annfar.2012.04.013
|
[158]
|
Terrence, C.F., Rao, G.R. and Perper, J.A. (1981) Neurogenic Pulmonary Edema in Unexpected, Unexplained Death of Epileptic Patients. Annals of Neurology, 9, 458-464. https://doi.org/10.1002/ana.410090508
|
[159]
|
Sedy, J., Kunes, J. and Zicha, J. (2015) Pathogenetic Mechanisms of Neurogenic Pulmonary Edema. Journal of Neurotrauma, 32, 1135-1145. https://doi.org/10.1089/neu.2014.3609
|
[160]
|
Wang, Y., Wang, Y., Chen, Y. and Qin, Q. (2020) Unique Epidemiological and Clinical Features of the Emerging 2019 Novel Coronavirus Pneumonia (COVID-19) Implicate Special Control Measures. Journal of Medical Virology, 92, 568-576. https://doi.org/10.1002/jmv.25748
|
[161]
|
Li, Y., Li, M., Wang, M., Zhou, Y., Chang, J., Xian, Y., et al. (2020) Acute Cerebrovascular Disease Following COVID-19: A Single Center, Retrospective, Observational Study. Stroke and Vascular Neurology, 5, 279-284. https://doi.org/10.1136/svn-2020-000431
|